Opioids and Public Health on Physicians' 2017 Legislative Agenda

Opioid-related legislation will focus mainly on mandated prescription drug monitoring program (PDMP) use but also on physician education, substance-use disorder treatment, and guidelines or restrictions on prescribing controlled substances

The American Medical Association's annual State Legislative Strategy Conference held earlier this month in Amelia Island, Fla., concluded with physician leaders agreeing the top issues to address with state legislators during 2017 include the opioid epidemic and strengthening public health, AMA Wire Staff Writer Troy Parks reported.

Strengthening Medicaid is one key topic, with many states preparing for debates this year about the future of Medicaid expansion and state medical associations seeking responsible Medicaid reforms that improve patient access and quality of care, Parks reported.

Others include reducing the U.S. opioid epidemic and advancing physician-led team-based care. Legislation will focus mainly on mandated prescription drug monitoring program (PDMP) use but also on physician education, substance-use disorder treatment, and guidelines or restrictions on prescribing controlled substances, Parks explained, adding that more access to naloxone and stronger Good Samaritan policies for anyone who aids someone experiencing an overdose are on the agenda.

AMA's Advocacy Resource Center tracked more than 450 scope-of-practice bills in 2016 that included provisions to establish a framework for physician-led team-based care, and several states will consider AMA model legislation, he wrote.

The public health efforts will concern vaccines, firearm safety, reproductive health, and other issues. "Assaults on the patient-physician relationship will continue in many states with legislation that attempts to decide what can and cannot be discussed in the exam room," Parks reported. "A number of states, including Iowa, Indiana, South Dakota, Vermont and Washington, aim to join California and Hawaii in raising the minimum purchasing age for tobacco products to 21. Missouri will attempt to ban texting while driving and fight against a repeal of the state’s helmet laws. State and national medical societies will be targeting a long list of additional issues such as diabetes prevention, decreasing cardiovascular disease, infectious disease prevention, obesity, student-athlete concussion and cardiac laws, women’s reproductive rights, tanning restrictions for minors and many others."

Product Showcase

  • The MGC Simple Plus

    The MGC Simple Plus is a simple-to-use, portable multi gas detector that runs continuously for three years without being recharged or routinely calibrated after its initial charge and calibration during manufacturing. The detector reliably tests a worksite’s atmosphere for hydrogen sulfide, carbon monoxide, oxygen and combustible gases (LEL). Its durability enables the detector to withstand the harshest treatment and environments, hence earning it an IP 68 rating. The MGC Simple Plus is also compatible with a variety of accessories, such as the GCT External Pump. Visit gascliptech.com for more information. Read More

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

Featured

Artificial Intelligence